215 results on '"Mendes-Bastos, Pedro"'
Search Results
2. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
3. Dupilumab‐assoziierte Gesichts‐ und Hals‐Dermatitis erfolgreich mit Baricitinib behandelt
4. Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
5. Biologic drugs in hidradenitis suppurativa: what does the GP have to know? A narrative review.
6. Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study
7. Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials
8. From PsO to PsA: the role of TRM and Tregs in psoriatic disease, a systematic review of the literature
9. 512 - Dupilumab treatment improves satisfaction in patients with prurigo nodularis who did not achieve the multicomponent endpoint: analysis from LIBERTY-PN PRIME and PRIME2
10. Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study
11. From PsO to PsA: the role of TRM and Tregs in psoriatic disease, a systematic review of the literature.
12. Real‐world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study.
13. Real‐world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study
14. Atopic dermatitis: improving patient access to health care in dermatology
15. Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis
16. Efficacy and Safety of Upadacitinib Treatment in Adolescents with Moderate-to-Severe Atopic Dermatitis:Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials
17. The use of ultrasound and magnetic resonance imaging in the management of hidradenitis suppurativa: a narrative review
18. 343 Dupilumab efficacy on itch and skin lesions in adult patients with prurigo nodularis may be observed concurrently or independently over 24 weeks: results from two phase 3 trials
19. Epidemiology of Psoriasis in Portugal: A Population-Based Study
20. Dupilumab treatment improves satisfaction in patients with prurigo nodularis who did not achieve the multicomponent endpoint: analysis from LIBERTY-PN PRIME and PRIME2.
21. Pathophysiology of hidradenitis suppurativa: a systematic review of the literature
22. Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials
23. 734 - Efficacy and safety of upadacitinib vs dupliumab in adults and adolescents with moderate-to-severe atopic dermatitis: results of an open-label, efficacy assessor-blinded head-to-head phase 3b/4 study (Level Up).
24. Lichen planus pemphigoides
25. Reflectance confocal microscopy for the diagnosis of Galli‐Galli disease
26. Multiple annular plaques on a 9‐year‐old boy
27. Persistence, effectiveness, and real‐world outcomes in psoriasis patients treated with secukinumab in Portugal
28. Bruton's tyrosine kinase inhibition - An emerging therapeutic strategy in immune-mediated dermatological conditions
29. Dermoscopic and reflectance confocal microscopic presentation of relapsing eccrine porocarcinoma
30. Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune‐mediated dermatological conditions
31. Perianal Paget disease secondary to pagetoid spread of mucinous adenocarcinoma of the anal canal
32. Dupilumab‐associated facial and neck dermatitis successfully treated with baricitinib.
33. Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients
34. Arrêt des dermocorticoïdes chez les patients atteints de dermatite atopique modérée à sévère : analyse de l’étude de phase 3 AD Up
35. Utilidade da Ecografia Cutânea na Celulite Dissecante: A Propósito de 2 Casos Clínicos
36. Allergic contact dermatitis caused by laurel leaf oil
37. Rasch wachsende schmerzhafte ulzerierende Plaques der Hände
38. Rapidly evolving painful ulcerated plaque on the hand
39. Imatinib: a novel treatment approach for generalized morphea
40. 43049 Efficacy and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Measure Up 1, Measure Up 2, and AD Up Phase 3 Clinical Trials at 52 Weeks
41. Nicht-berufsbedingte allergische Kontaktdermatitis durch Azithromycin-haltige Augentropfen: Non-occupational allergic contact dermatitis caused by azithromycin in an eye solution
42. Non-occupational allergic contact dermatitis caused by azithromycin in an eye solution
43. Secukinumab: A complete approach to psoriatic patients—Real‐world evidence study
44. VENUS Study: ViEw of HidradeNitis SuppUrativa by PortugueSe General Practitioners
45. Dermoscopy and reflectance confocal microscopy for the diagnosis of scleromyxedema
46. VENUS Study: ViEw of HidradeNitis SuppUrativa by PortugueSe General Practitioners
47. Beyond striae cutis: A case report on how physical skin complaints unveiled end-of-life total experience
48. Manifestações Cutâneas em Doentes com COVID-19
49. Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study
50. Dermatite Atópica: O Futuro é Agora
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.